GeneSight® GUIDED Study Published in the Journal of Psychiatric Research
Large, Blinded Prospective Study Demonstrates that GeneSight Improves Clinical Outcomes in Patients with Treatment Resistant Major Depressive Disorder SALT LAKE CITY, Utah, Jan. 4, 2019 –Myriad Genetics, Inc. (NASDAQ: MYGN),…